KSA Performance — iShares MSCI Saudi Arabia ETF
Data updated: 2026-07-27
KSA returned +5.97% year to date and +3.47% over one year to May 2026. Annualised returns are +1.69% over 3 years and +2.66% over 5 years. The fund trailed its Saudi Arabia Equity category average: $100 invested three years ago grew to $105, against $106 for the category, and to $103 over one year, against $104. Volatility over the past three years was 14.34% a year. In the 12 months to May 2026 the fund took in a net $4.4M, and assets reached $686.26M.
KSA Growth of $100
What $100 invested in iShares MSCI Saudi Arabia ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Saudi Arabia Equity category average over the same months.
| Period | KSA | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $103 | $104 |
| 3 years (Jun 2023 – May 2026) | $105 | $106 |
| 5 years (Jun 2021 – May 2026) | $114 | $116 |
| Since data start (Sep 2019 – May 2026) | $149 | $153 |
KSA Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.97% |
| 1 year | +3.47% |
| 3 years (annualised) | +1.69% |
| 5 years (annualised) | +2.66% |
KSA Annual Returns
Calendar-year total returns of iShares MSCI Saudi Arabia ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +5.97% |
| 2025 | −8.26% |
| 2024 | +0.53% |
| 2023 | +13.60% |
| 2022 | −5.48% |
| 2021 | +33.77% |
| 2020 | +2.42% |
| 2019 (Sep–Dec) | +3.80% |
KSA Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +8.9% | −5.9% | +5.2% | −0.2% | −1.5% | — | — | — | — | — | — | — |
| 2025 | +2.8% | −1.9% | −0.2% | −1.8% | −5.0% | +1.8% | −1.8% | −0.8% | +7.7% | +1.0% | −8.4% | −1.1% |
| 2024 | −0.8% | +7.1% | −1.1% | −2.2% | −7.0% | +2.9% | +2.9% | +0.7% | +1.0% | −1.9% | −3.0% | +2.7% |
| 2023 | +2.8% | −6.9% | +6.3% | +6.3% | −2.5% | +4.3% | +1.3% | −2.6% | −4.1% | −3.2% | +5.0% | +7.3% |
| 2022 | +10.0% | +2.2% | +3.5% | +5.2% | −6.8% | −10.7% | +6.3% | +1.1% | −7.5% | +3.6% | −6.2% | −4.0% |
| 2021 | +1.6% | +4.0% | +8.8% | +6.4% | +0.6% | +4.0% | +0.4% | +4.0% | +1.8% | +2.7% | −8.8% | +4.9% |
| 2020 | −2.4% | −8.3% | −14.4% | +10.8% | +1.9% | +0.8% | +2.4% | +5.5% | +2.8% | −3.3% | +9.7% | −0.3% |
| 2019 | — | — | — | — | — | — | — | — | +0.4% | −4.4% | +1.5% | +6.5% |
KSA Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 14.34%
- 3-year Sharpe ratio: -0.20 (vs 4.5% risk-free rate)
- Best month: +8.94% (Jan 2026)
- Worst month: −8.41% (Nov 2025)
KSA Fund Flows
Monthly money in and out of iShares MSCI Saudi Arabia ETF, from SEC Form N-PORT.
- 12-month net flow: $4.4M
- 12-month gross sales (incl. reinvestments): $234.9M
- Sales ÷ redemptions: 1.02×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $0 | $25.1M | −$25.1M |
| Apr 2026 | $0 | $15.7M | −$15.7M |
| Mar 2026 | $41.9M | $0 | $41.9M |
| Feb 2026 | $35.3M | $0 | $35.3M |
| Jan 2026 | $0 | $9.0M | −$9.0M |
| Dec 2025 | $0 | $13.0M | −$13.0M |
| Nov 2025 | $3.8M | $49.3M | −$45.4M |
| Oct 2025 | $14.3M | $0 | $14.3M |
| Sep 2025 | $130.2M | $19.6M | $110.6M |
| Aug 2025 | $0 | $75.8M | −$75.8M |
| Jul 2025 | $0 | $23.0M | −$23.0M |
| Jun 2025 | $9.3M | $0 | $9.3M |
KSA Assets Under Management
Net assets of iShares MSCI Saudi Arabia ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $686.26M |
| 2026-02-28 | $661.61M |
| 2025-11-30 | $649.97M |
| 2025-08-31 | $581.57M |
| 2025-05-31 | $686.48M |
| 2025-02-28 | $636.21M |
| 2024-11-30 | $619.60M |
| 2024-08-31 | $613.13M |
| 2024-05-31 | $726.26M |
| 2024-02-29 | $859.54M |
| 2023-11-30 | $732.12M |
| 2023-08-31 | $963.82M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.